Migraine pathogenesis and state of pharmacological treatment options
Open Access
- 16 November 2009
- journal article
- review article
- Published by Springer Nature in BMC Medicine
- Vol. 7 (1) , 71
Abstract
Migraine is a largely inherited disorder of the brain characterized by a complex, but stereotypical, dysfunction of sensory processing. Often the most obvious clinical symptom is head pain, but non-headache symptoms such as photophobia, phonophobia and nausea are clearly part of the typical presentation. This review discusses the current pathophysiological concepts of migraine and migraine aura, such as a possible brainstem dysfunction and cortical spreading depression. Acute and preventive migraine treatment approaches are briefly covered with a focus on shortcomings of the currently available treatment options. A number of different receptors, such as calcitonin gene-related peptide (CGRP), TRPV1 and glutamate receptors, are currently being targeted by potential novel migraine therapeutics. The prospects of this research are exciting and are likely to improve patient care.Keywords
This publication has 46 references indexed in Scilit:
- Phenotype-Driven Preventive Strategies for Migraine and Other HeadachesThe Neurologist, 2009
- Are Cortical Spreading Depression and Headache in Migraine Causally Linked?Cephalalgia, 2009
- Is migraine a genetic illness? The various forms of migraine share a common genetic causeNeurological Sciences, 2008
- Emerging therapies for migraineNature Clinical Practice Neurology, 2007
- NEUROGENIC INFLAMMATION AND MIGRAINE: IMPLICATIONS FOR THE THERAPEUTICSMolecular Interventions, 2005
- The CGRP-Antagonist, BIBN4096BS Does not Affect Cerebral or Systemic Haemodynamics in Healthy VolunteersCephalalgia, 2005
- The Premonitory Symptoms (Prodrome): A Tertiary Care Study of 893 MigraineursHeadache: The Journal of Head and Face Pain, 2004
- Consensus Statement: Cardiovascular Safety Profile of Triptans (5‐HT1B/1D Agonists) in the Acute Treatment of MigraineHeadache: The Journal of Head and Face Pain, 2004
- Nitric oxide synthase inhibition in migraineThe Lancet, 1997
- Cortical spreading depression recorded from the human brain using a multiparametric monitoring systemBrain Research, 1996